Lilly has the edge on Danish rival Novo to weather potential U.S. price cuts on its blockbuster obesity drug Zepbound, backed ...
In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...
Lilly partners with Walmart to offer weight-loss drug Zepbound at nationwide pharmacies, expanding access to the medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback